Source: JAMA Internal Medicine, Visualmed
More from
Key Takeaways: The OPTION TRIAL assessed the safety and efficacy of WATCHMAN FLX in a… Continue Reading
Key Points: Over 6 million people in the US live with heart failure (HF), but… Continue Reading
Key Points SUMMIT, a randomized control trial of tirzepatide versus placebo in patients with HFpEF… Continue Reading
Leave a Reply
You must be logged in to post a comment.